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"What the caterpillar thinks is the end of the world ... the
butterfly knows is only the beginning."
-Anonymous
Institute of Medicine Second Report

The Institute of Medicine (10M) issued its first report at the end
of 1999 concerning patient safety and succeeded in getting the
attention of the public, the third-party payers and the health
care industry, for a problem that apparently has been around
for a number of years. In an interview with Dr. Lonnie Bristow,
former president of the AMA and member of IOM,
(www.physiciansnews.com) he describes the response of
industry in forming the Leapfrog group (large Fortune 500
companies) and restructuring their insurance programs to
reward those hospitals that are attempting to respond to
patient safety concerns. He describes the president endorsing
the safety focus in the VA system and all governmental
(health) entities. He focused primarily on the second 10M
report published in March 2001 titled "Crossing the Quality
Chasm: A new health care system for the 21 5' century."
"Both reports identify that the problems either with safety or the
overall quality of care in America lie with the systems of care
that we give to Americans. That's terribly important. .. Health
care, as it is rendered in America, frequently was organized in
a fashion that was for a different time, not for the 21 51
century ... That's marvelous news because it means that it's not
really about incompetent physicians or nurses, or uncaring
hospitals. In fact, the final report states very clearly that we
are not going to achieve substantial improvement in the quality
of care by simply exhorting those particular players to work
harder to make the quality of care better. They can't. .. This is
good news because it means we can stop beating up on each
other and begin to look at the systems of care that we use,
some of which were developed hundreds of years ago, for
example, the way we write prescriptions." (my underlines)
The roadmap report goes on to discuss changes in medical
education, chronic disease management (15 chronic diseases
to be identified by AHCRQ), and 10 golden rules to guide
innovation "such as customizing care based on patient needs
(Continued on Page 2)
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and values, giving patients unfettered access to their own
medical information, using evidence-based decision-making,
anticipating patient needs rather than reacting to them,
decreasing waste of resources or patient time, and ensuring
cooperation among clinicians and institutions."

"The need for change? Well, let's take a lesson from nature:
grow or die."
-Tor Dahl- Presentation@ Governance Institute 3/27/01

Does some of the report below seem far-fetched? As Leonard
Parker Pool said 27 years ago, "look about you." LVH has
already started the technology metamorphosis.
A Fully Digital Medical Center is being built in Birmingham by
HealthSouth Corp. and Oracle Corp.
The joint venture between the operator of rehabilitation
hospitals and surgery centers and the software developer will
feature beds with Internet-linked computer screens, electronic
medical-record systems, digital imaging instead of traditional
X-ray film and a wireless communications network to provide
physicians with real-time information about patients, while
Internet links to physician offices will enable patients to be
admitted to the hospital electronically from their doctor's office
rather than having to wait and fill out paperwork upon arrival,
the Wall Street Journal reported. The full-service, 218-bed
hospital is slated for completion by late 2003 and may serve as
a prototype for as many as ten more to be built in different
markets over several years, the Journal added, citing Richard
Scrushy, HealthSouth chairman and chief executive. (Wall
Street Journal, March 27, 2001)
http://interactive. wsj.com/articles/SB985645540678313327. htm

"Hear that sound, Morpheus? ... that's the sound of
inevitability."
- Agent Smith in the movie, "The Matrix"

PA Malpractice Crisis Continues- "We can't fight this alone" Dr. Carol Rose

awards." Pennsylvania Medical Society President Carol E.
Rose explains: "After extensive study and consultation with the
nation's top medical liability experts, your State Society
concluded that only a multi-stage plan could finally and fully
solve this very complex problem. •
She then describes the five-part plan, including immediate
legislative relief, long term legal reform, a constitutional
amendment, judicial reforms and a public awareness
campaign.
I urge you to contribute to this effort on our behalf and support
your medical society. If you don't think this is your fight too,
check your malpractice premium for this year.
"The Medical Society is the only organization in this fight for
the long run. We're the only ones in it for our profession, and
to protect the physician-patient relationship. n

Never be afraid to try something new. Remember, amateurs
built the ark, professionals built the Titanic.

Last month, we expressed real concern (and surprise) about
the selling of prescribing information - which I now find is
relatively common. With all the discussion about the upcoming
Health Insurance Portability and Privacy Act, we expect more
rulings like the case below:
A New York Court Ruled that Pharmacists Could Have a Duty
to Keep Customers' Prescriptions and Medical Histories
Confidential
In what is believed to be a first-of-its-kind ruling on a
pharmacy's role in prescription privacy, the court ruled last
month that a man with AIDS will be allowed to go forward with
a lawsuit that claims his privacy was violated when a local
pharmacy went out of business and sold his records to a
national chain without his consent, reported AMNews. In
recent years, physicians have raised concerns that drug
manufacturers and insurance companies are gaining too much
access to doctors' prescribing patterns and to patient
information through prescription records. (American Medical
News, April2, 2001)
http://www.ama-assn.om/scipubs/amnews/pick 01 /prsb0402.htm

In the March/April 2001 Supplement to Pennsylvania Medicine:
"In 2001, forces combined to make the CAT Fund an
intolerable burden - the hardening of the insurance market,
increases in premiums and skyrocketing medical liability court

E-mail surrogates and GUI- Graphic User Interface (sounds
kinky - try it, you'll like it)
(Continued on Page 3)

(Continued from Page 2)

The program to communicate with the medical staff on a timely
basis using e-mail is working. Our feedback indicates that a
substantial number of the medical staff (or their surrogates)
read their e-mail. I would like to thank the Physician Relations
team (POPS} and LVH Information Services for their work in
this area. We are encouraging all users to employ the GUI
system for their e-mail. Once again, if you do not pers?nally
use the e-mail system, designate a surrogate (usually 1n your
office) to print it for you. The system can work for you- and
ifs painless. We are declaring cyber-amnesty. Just call Pat
Skrovanek in Physician Relations at (610) 402-9190.
You can communicate with medical staff leadership directly via
e-mail (generally all your suggestions a~d com~ents are.read
and discussed at Troika}. You have a d1rect vo1ce- albeit, an
electronic one - but a voice nonetheless to your elected
representatives who want to know your concerns, issues, and
views.

Physicians' Recognition Dinner- 2001
The March 31 event was a very memorable and enjoyable
evening for our medical staff. I have received significant
positive feedback. I would like to thank Dr. Elli~t Sussman and
Mr. Marv Woodall for their comments. I would like to add
special thanks to Janet Seifert and ~eth Martin, as. w~ll as the
entire staff of the Medical Staff Serv1ces office -- Cmd1 Ault,
Karen Fox, Marge Kratzer, Rita Mest, Kathy Schaeffer, Pat
Skrovanek, and Lori Tucker.

Golfer: "Please stop checking your watch all the time, caddy.
lfs distracting."
Caddy: "This isn't a watch, sir. It's a compass."

Physicians Honored for Career Milestones
Over 60 members of the Lehigh Valley Hospital (LVH) medical
staff were honored for their years of service, commitment and
dedication at the 2001 Physician Recognition Dinner held at
the Holiday Inn Conference Center, Fogelsville, on March 31.
Edward M. Mullin, Jr., MD, President of the LVH medical staff,
told more than 300 physicians, board members, hospital
administrators and guests that his colleagues were being
recognized for their service to patients and the community in
partnership with LVHHN. "We've chosen a demanding field
only we can truly understand. All of us can take satisfaction in
this accomplishment. •
Receiving special recognition were past presidents of the .
medical staff, physicians who served 50 years on the med1cal
staff and those who served 25 years.
Past presidents who were honored include David M. Caccese,
MD, Department of Medicine, Division of General Internal
Medicine, and Robert X. Murphy, Jr., MD, Department of
Surgery, Division of Plastic Surgery.
Honored for 50 years of service were Charles D. Schaeffer,
MD, Department of Surgery, Division of General Surgery.' ~~d
Lawrence M. Weisbrod, MD, Department of Surgery, D1v1s1on
of Orthopedic Surgery.
Those honored for 25 years of service include:

Department of Anesthesiology
•!• ln·Ho Chang, MD
•!• Ramon J. Deeb, MD
•!• Howard E. Hudson, Jr., MD
•!• Jay S. Jung, MD
•!• Samuel M. Lerner, MD
•!• Carmen B. Montaner, MD
•!• Toeruna S. Wldge, MD
•!• Wen-Shiong Yang, MD

DepartmentofDentis&y
Edward M. Mullin, Jr., MD
Medical Staff President

•:• Russel S. Bleiler, Jr., DDS, Division of General
Dentistry/Special Care
•!• Peter T. Davis, DDS, Division of Prosthodontics
•!• Michael F. Lentz, DDS, Division of General
Dentistry/Special Care
•:• Dominic P. Lu, DDS, Division of General
Dentistry/Special Care

Department of Emergency Medicine
•:• Joseph J. Fassl, MD
•:• Ronald A. Lutz, Sr., MD
(Continued on Page 4)
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Department of Family Practice
•!• LeRoy B. Gerchman, MD
•!• Dennis M. McGorry, DO, Section of Geriatrics
•!• John J. Mecca, MD

Department of Medicine
•!• Lloyd E. Barron II, MD, Division of Hematology-Medical
Oncology
•!• Ki T. Boo, MD, Division of General Internal Medicine
•!• Charles M. Brooks, MD, Division of Gastroenterology
•!• David M. Caccese, MD, Division of General Internal
Medicine/Geriatrics
•!• Joseph V. Episcopio, MD, Division of General Internal
Medicine
•!• Peter K. Ghatak, MD, Division of General Internal
Medicine
•!• Robert W. Grunberg, MD, Division of Nephrology
•!• John B. Longenhagen, MD, Division of General Internal
Medicine
•!• John K. Mahon, MD, Division of Neurology
•!• James A. Pantano, MD, Division of Cardiology
•!• Robert M. Post, MD, Division of Hematology-Medical
Oncology
•!• Cynthia D. Starr, MD, Division of Hematology-Medical
Oncology

Department of Obstetrics and Gynecology
•!• Ernest Y. Normington II, MD, Division of Primary
Obstetrics and Gynecology

Department of Pathology
•!• Arthur A. Altman, MD, Division of Anatomic Pathology
•!• Raymond A. Rachman, MD, Division of Anatomic
Pathology
•:• Michael Scarlato, MD, Division of Anatomic Pathology
•!• John J. Shane, MD, Division of Anatomic Pathology

Department of Pediatrics
•!• Martha A. Lusser, MD, Section of Neurology
•!• Charles F. Smith, MD, Division of General Pediatrics

Department of Psychiatry
•!• Paul K. Gross, MD, Division of Adult Inpatient Psychiatry

Department of Radiology-Diagnostic Medica/Imaging
•!• Stanley Benzel, MD, Division of Diagnostic Radiology
•!• Robert Kricun, MD, Division of Diagnostic Radiology
•!• Thomas E. Leet, MD, Division of Diagnostic Radiology
•!• Zwu S. Lin, MD, Division of Diagnostic Radiology
•!• Alan H. Wolson, MD, Division of Diagnostic Radiology,
Section of Chest

Department of Surge~
•!• George A. Arangio, MD, Division of Orthopedic Surgery,
Section of Ortho Trauma
•!• Pricha Boonswang, MD, Division of Colon and Rectal
Surgery
•!• Tamar D. Earnest, MD, Division of General Surgery
•!• J. Victor Ehrens, DMD, Division of Oral and Maxillofacial
Surgery
•!• Walter J. Finnegan, MD, Division of Orthopedic Surgery
•:• William W. Frailey, Jr., MD, Division of General Surgery
•!• Charles S. McConnel, Jr., MD, Division of
Otolaryngology-Head &Neck Surgery
•!• Kenneth M. McDonald, MD, Division of Vascular Surgery
•!• Edward M. Mullin, Jr., MD, Division of Urology
•!• Farrokh S. Sadr, MD, Division of Cardia-Thoracic Surgery
•!• Charles J. Scagliotti, MD, Division of General
Surgery/Trauma-Surgical Critical Care
•!• Paul H. Schenck, MD, Division of Ophthalmology
•!• John J. Stasik, MD, Division of Colon and Rectal Surgery
•!• David B. Sussman, MD, Division of Orthopedic Surgery,
Section of Ortho Trauma
•!• William M. Trachtenberg, MD, Division of Ophthalmology
•!• Howard D. Trimpi, MD, Division of Colon and Rectal
Surgery

The Physician Recognition Dinner is held every three years to
recognize and acknowledge the countless efforts and
contributions made by physicians to Lehigh Valley Hospital
and Health Network. This year's dinner was the first since the
medical staffs of Lehigh Valley Hospital and Lehigh Valley
Hospital-Muhlenberg merged in December 1998.

Medical Staff Progress Notes
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Radiology News
PET Scanning Has Arrived!
Positron Emission Tomography (PET) is now available at
Lehigh Valley Hospital, Cedar Crest & 1-78. CDL Medical
Technologies has been contracted to provide mobile PET
services to LVH. The system that has been chosen is a stateof-the-art Siemen's dedicated PET scanner which can detect
lesions as small as several millimeters. Scanning will initially
be performed one day per week with the potential of expanded
services as volume builds.
The clinical usefulness of PET will mainly be in the field of
oncology. PET utilizes an isotope of glucose, i.e., 2-deoxy-2[1BF] fluoro-D-glucose (FDG). Since most tumors have high
glyolytic rates, FDG uptake is seen in many tumors. PET FDG
has been shown to detect tumor foci of a variety of histologic
types.
PET is unique in providing functional assessment of the
anatomic abnormalities usually found on CT or MRI scans.
Studies indicate that PET may be used as a compliment to CT
by helping to characterize, as benign or malignant, solitary
pulmonary nodules found to be indeterminate on CT. By
reducing false-positive studies, radiologists can more
accurately identify patients for surgical resection and decrease
unnecessary interventions for benign nodules.
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PET scans are currently approved by HCFA for the following
indications:
~
~

Characterization of solitary pulmonary nodules
Initial staging and follow-up of:
•
•
•
•

non-small cell lung cancer
colorectal cancer
melanoma
Hodgkin's and non-Hodgkin's lymphoma

These studies will be interpreted by Nuclear Medicine
physicians, Robert Rienzo, MD, and Kathleen McDonald, MD,
who are board certified by both the American Board of
Radiology and the American Board of Nuclear Medicine.
If you have any questions concerning PET, please contact
either Dr. Rienzo or Dr. McDonald in Nuclear Medicine at (610)
402-8373.
(Some of the information in this article was obtained from the Oncology
Roundtable of the Advisory Board Company of Washington, D. C.)

Nuclear Medicine Reminder
Federal and State regulations governing the medical use of
radioactive materials define a misadministration as one
involving administration of a radiopharmaceutical (1) to the
wrong patient, (2) involving the wrong route of administration,
or (3) administration of a radiopharmaceutical other than the
one intended or prescribed. Misadministrations compromise
patient care, as well as representing significant violations of
our radioactive materials license conditions.

PET is important in tumor staging. For example, in the
evaluation of a patient with non-small cell lung cancer,
accurate evaluation of the mediastinum is important for staging
and treatment decisions. PET can detect tumors in normal
sized lymph nodes and, therefore, more accurately stage
patients with lung cancer. PET can improve the sensitivity and
specificity for mediastinal staging of these patients.

Prevention of misadministrations requires diligence by all
parties with respect to making certain that the clinical objective
of all diagnostic exams or radiopharmaceuticals are
understood and met.

PET also has been shown to increase accuracy in detecting
recurrent disease in patients with colorectal cancer and
melanoma. PET can detect small tumor foci in patients with
colon cancer with a rising CEA level and a normal or equivocal
CT scan. PET can help stage Hodgkin's and non-Hodgkin's
lymphoma much better than Gallium scans.

Toward this end, all referrals for radiopharmaceutical-based
procedures must be made by prescription. Also, please stress
to your patients that they present the prescription to the
attending Nuclear Medicine technologist at the time of their
exam. No procedure will be preformed without a
prescription.

There are some limitations to PET scanning. Although
specificity is usually high, inflammatory or infectious processes
may result in false-positive interpretations. Also, PET does not
provide the level of precise anatomic localization of tumor
required for surgical excision or targeted radiation therapy and
requires complimentary anatomic correlation with CT or MRI.

Thank you for your attention to this issue. If you have any
questions, please contact Bernard Valasek, Nuclear Medicine
Technologist (Cedar Crest &1-78), at (610) 402-8390, or
Sandra Bobryk, Lead Technologist, Nuclear Medicine (LVHMuhlenberg), at (484) 884-2235.

The relative amount of radiation to a patient from a PET FDG
scan is similar to that of a body computed tomography scan.

Please Note • The telephone number for the Nuclear
Medicine Physicians' Viewing Room at Cedar Crest &1-78
has been changed to (61 0) 402·8373.
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News from CAPOE Central
Several weeks ago, I was demonstrating the CAPOE system
to a group of doctors. They were impressed by the capabilities
of the system, including the ability to look up and re-activate
orders from previous admissions, the use of order sets, and
the allergy and drug interaction checking. However, like many
of the medical staff, one of them was concerned about the time
required to enter orders into the computer. He wrote out eight
separate orders and handed them to me. "Now, enter these as
quickly as you can," he challenged. I would have complied,
but I could not read the first two orders he had written (and
neither could one of the other people in the room}. I was
tempted to page him an hour later to ask him for clarification of
his orders (as would have happened in the hospital}.
A recent report was released by the Agency for Healthcare
Research and Quality entitled, "Research in Action: Reducing
and Preventing Adverse Drug Events (ADE} to Decrease
Hospital Costs.· Highlights from the report follow:
• Incidence rates of ADEs vary from 2 per 100 admissions
to 7 per 100 admissions among the hospitals that have
conducted ADE studies.
• Anywhere from 28 percent to 95 percent of ADEs can be
prevented by reducing medication errors through
computerized monitoring and order entry systems.
• For example, at least two studies attribute 42-60 percent
of ADEs to excessive drug dosage for the patient's age,
weight, underlying condition, and renal function.
• According to another AHRQ-funded study at Brigham and
Women's Hospital, computerized medication order entry
has the potential to prevent an estimated 84 percent of
dose, frequency, and route errors. Their system, which is
similar to our CAPOE system, eliminates illegible orders
that lead to medication errors. Programmed within the
system are algorithms that check dosage frequency,
medication interactions, and patient allergies.
• Patients who experienced adverse drug events (ADEs}
were hospitalized an average of 8 to 12 days longer than
patients who did not suffer ADEs, and their hospitalization
cost $16,000 to $24,000 more.
• Hospitals can save as much as $500,000 annually in
direct costs by using computerized systems.
The literature continues to provide evidence that physician
order entry improves the quality of care. I believe that with
CAPOE, we are on the correct path to achieve this goal while
having an overall beneficial impact on the work process of our
physicians/providers.
We will provide an opportunity for true "hands-on" experience
with CAPOE outside the Cedar Crest & 1-78 Auditorium all day
on Tuesday and Wednesday, May 8 and 9. There will be live
demonstrations and workstations set up to provide physicians
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and staff an opportunity to "play with the system. • Please stop
by and give it a test drive.
Don Levick, M.D., MBA
(484} 884-4593
(610} 402-5100 7481 (pager}

Recommendation from the Therapeutic
(Transfusion) Committee: Blood
Infusion Rates
By Bala B. Carver, MD, Chief, Section of Transfusion Medicine & HLA

Red Blood Cells:
In a clinically stable patient, red blood cells should be
infused over 1.5-2 hours.
It was brought to the committee's attention that many
transfusions are being given over 3-4 hours. Blood is
an excellent culture medium and, at room
temperature, the potential of bacterial growth exists
which is directly proportional to the length of time the
blood is at room temperature.
If rapid transfusion is needed, blood can be infused
as rapidly as the patient's circulatory system will
tolerate, and the type of vascular access will allow. If
there is a concern about the fluid status of the patient
and a slower transfusion is required, either the unit
should be divided into two or the patient should be
premedicated with a diuretic.
Other Blood Components (e.g., fresh frozen plasma,
platelets, cryoprecipitate):
These other components can be infused as rapidly as
the patient will tolerate.
The infusion rate needs to be ordered for each transfusion on
the Blood Component Transfusion Order form.
If you have any questions regarding this issue, please contact
Bala B. Carver, MD, Chief, Section of Transfusion Medicine &
HLA, at (610} 402-8142.
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Physician Assistant Order Writing
Recently, a number of questions have been raised as to what
physician assistants can do. The following list of medications
can be prescribed by a physician assistant, if so delegated by
a physician assistant supervisor (a physician who is identified
as the supervising physician of a physician assistant in the
written agreement and is registered with the Medical Board as
such). Written agreements need to be submitted to the
Medical Staff Office.
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>
);>

Antihistamines
Anti-infective agents
Cardiovascular drugs
Contraceptives - eg: foams and devices
Diagnostic agents
Disinfectants -for agents used on objects other then skin
Electrolytic, caloric and water balance
Enzymes
Antitussives, expectorants, mucolytic agents
Gastrointestinal agents
Local anesthetics
Serums, toxoids and vaccines
Skin and mucous membrane agents
Smooth muscle relaxants
Vitamins

Categories from which Physician Assistants May
Prescribe (subject to exclusions and limitations listed)
Autonomic drugs
Drugs excluded under this category:
);> Sympathomimetic (adrenergic) agents
Blood formation and coagulation
Drugs excluded under this category:
);> Anti-coagulants and coagulants
);> Thrombolytic agents
Central Nervous System agents
Drugs excluded under this category:
);>
);>

General anesthetics
Monoamine oxidase inhibitors

Eye, ear, nose and throat preparations
Drugs limited under this category:
);> Miotics and mydriatrics used as eye preparations require
specific approval from the physician assistant supervisor
for a named patient.
Hormones and synthetic substitutes
Drugs excluded under this category:
);> Pituitary hormones and synthetics
);> Parathyroid hormones and synthetics

Categories from which Physician Assistants May Not
Prescribe or Dispense
);>
);>
);>
);>
);>
);>
);>
);>
);>

Antineoplastic agents
Dental agents
Gold compounds
Heavy metal antagonists
Oxytocics
Radioactive agents
Unclassified therapeutic agents
Devices
Pharmaceutical aids

A physician assistant may not prescribe or dispense Schedule
1or II controlled substances (i.e., Morphine, Percocet, etc.)
A physician assistant may not prescribe whole blood and blood
components.
It is important to understand what physician assistants may or
may not do. If an order is written for a medication or blood
product which is not approved according to the State Rules
and Regulations, a nurse cannot act on the order, the Blood
Bank cannot dispense the blood, or the Pharmacy cannot
dispense the medication, unless co-signed by the physician
assistant supervisor.
If you have any questions or concerns regarding this issue,
please contact Rita M. Mest, Director, Medical Staff Services,
at (610) 402-8975, or Fred J. Pane, R.Ph., Director, Pharmacy,
at (610) 402-8882.
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A Word About Consults
By David M. Caccese, MD, Division of General Internal Medicine/Geriatrics

Envision the following all too common scenario: You've been
working at the hospital and in your office all day. You started
rounds at the hospital at 7 a.m. After a long afternoon in the
office, you do get home to have dinner with your family. Since
you are on call for your group, you have to go back to the
hospital after dinner to evaluate and admit two patents that are
in the emergency room. Finally, at 10:30 p.m., you are able to
leave the hospital and drive home. You're fatigued after a long
day, but are hopeful that the remainder of the night "won't be
too bad."
Shortly after getting home and turning on the 11 p.m. news,
your pager goes off with a message to call your answering
service. You call immediately and are told by the answering
service operator that there is an "urgent consult" at LVH. The
consult request simply says "please see tonight!" No other
information is given, other than the name of the patient's
attending physician, and patient's room location.
Think about the reaction that all of us have had in this
unfortunately, not uncommon situation. First, there is a rapid
rise in systemic catecholanine levels. Anger follows. This is
frequently followed by an expletive. Then the questions begin:
"What is wrong with the patient?" "Why do I need to see the
patient tonighr?" "Do I really need to see the patient tonighr?"
"Why didn't the doctor who wanted me to see his/her patient
tonight call me to tell me what this was all about?"
All of us have been confronted with the above scenario at some
point in our careers. What is the answer for this problem? One
word helps to diffuse the issue-- COMMUNICATION!!
We are professionals. We expect and want to be treated as
professionals by our patients, our nursing colleagues in the
hospital, and especially by our physician colleagues. How
much better would it be for us as individual physicians if the
above scenario did not occur as frequently as it does?
Wouldn't it be better for patient care (and physician
catecholamine levels) if the physician requesting an urgent
consultation had the courtesy and respect for his professional
colleague to call him/her and tell him why he was requesting
an urgent consultation on the patient? The requesting
physician might be able to provide important historical
information, and most importantly, would be able to ask the
question which the consultant was to address in an urgent
fashion.
Communication between professionals could help to build a
better working relationship. It might even result in a long
lasting referral relationship that could benefit both parties.
Most of all, it would improve the quality of patient care. Think
about it!

Sleep Disorders Center Relocating to
17th & Chew
On May 1, the Sleep Disorders Center, which has been
located at Cedar Crest &1-78, will move to the fourth floor of
Lehigh Valley Hospital at 17th &Chew. The new laboratory,
with improved diagnostic equipment, will expand from its
current six beds to 13 beds effectively doubling the ability to
perform sleep studies. In addition to expanding in capacity,
the new Center will offer significant improvements in comfort to
patients including a private bath with a shower in each room,
televisions, refreshment center, and attractive "hotel room"
decor. For patients' convenience, valet parking will be
available at the front entrance of the hospital.
To schedule an appointment, please contact Central
Scheduling at (610) 402-8378 (TEST). For information about
sleep studies, please contact the Sleep Disorders Center at
(610) 402-9777.
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Central Scheduling to Handle Reservations
for MRI and Sleep Disorder Studies at LVH-M
Beginning April 30, the Central Scheduling Department will
handle reservations for MRI and Sleep Disorder Studies at
LVH-Muhlenberg. Previously, the individual departments
handled the scheduling of reservations. This change is part of
the continuing effort to streamline access to the services
available at LVH-Muhlenberg.
In order to expedite the scheduling process, please have the
patient's demographic information, including their insurance
information, available at the time of the scheduling call. As
with the other tests and procedures you order through Central
Scheduling, this will allow patients to be pre-registered and
speed the intake process when they arrive at the hospital.
To schedule an MRI or Sleep Disorder Study at LVHMuhlenberg, please call Central Scheduling at (484) 884-2279,
Monday through Friday, from 7 a.m. to 7 p.m.
If you have any questions, comments or concerns, please
contact Lisa Coleman, Director, Support Services, at (610)
402-8066, or Mark Holtz, Vice President of Operations, at
(484) 884-4710.
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Infection Control News
Animal bites are listed as reportable diseases in the
Commonwealth of Pennsylvania. Health care providers are
required to immediately report all types of animal bites to
their local Health Bureau. This includes all warm-blooded and
cold-blooded animals (snakes and other reptiles). Rapid
reporting of animal bites assists the Health Bureau in helping
to identify dangerous animals and removing them from the
community, if necessary, or by requiring owners to properly
restrain and vaccinate pets. Reportable disease forms are
available from the Health Bureau.
Allentown Health Bureau
245 N. 61h Street
Allentown, PA 18102
Phone: (610) 437-7577
Page: (610) 218-3266
Fax:
(610) 437-8799
Bethlehem Health Bureau
10 E. Church Street
Bethlehem, PA 18018
Phone: (610) 865-7087
Fax:
(610) 865-7019
Lehigh County PA·DOH
3730 Lehigh Street
Whitehall, PA 18052
Phone: (610) 821-6770
Emergencies: (717) 826-2062
Fax:
(610) 821-6564
If you have any questions regarding this issue, please contact
a member of the Infection Control Department at (61 0) 4020680.

Osteoporosis: Could Your Patients Be
At Risk?
Osteoporosis arises when the balance between bone
formation and bone resorption is disrupted in favor of bone
resorption. It is a widespread condition affecting more than 28
~illion individu~ls in the U.S. In a demographic analysis of a
mne county reg1on of Pennsylvania (including Lehigh County)
conducted a few years ago, one-third of all women and men
age 45-75+ were found to have osteoporosis or to have low
bone mass and be at risk for osteoporosis. As a silent risk
factor for fracture, osteoporosis represents a major cause of
morbidity, hospitalization and mortality. One of every two
white women will experience an osteoporotic fracture
sometime in her lifetime.

Osteoporosis is a multifactorial condition with well-recognized
risk factors. These include: age, gender, genetics, body size,
lifestyle factors, other illnesses and drug treatments. Bone
density declines after age 30, particularly in post-menopausal
women. While the lighter and smaller skeleton of women
make them more likely to develop osteoporosis, 20% of all
people with osteoporosis are men. Caucasians and Asians
have a higher prevalence of osteoporosis. Excessive alcohol
consumption, tobacco use, sedentary lifestyle, and a diet low
in calcium increase the risk for osteoporosis. Illnesses that
speed bone loss or cause immobility increase risk.
Medications that affect bone metabolism include:
Glucocorticoids, Adrenocorticotrophin, excessive use of
Thyroxine, Anticonvulsants, long term Heparin use, Lithium,
Cytotoxic drugs (Methotrexate), Aluminum, Gonadotrophinreleasing hormone agonists, and Cyclosporin A. Early
identification of individuals at risk and implementation of
preventative measures, where possible, can result in
minimization of bone loss, better skeletal preservation, and
reduction in fracture risk.
Osteoporosis is not an inevitable aspect of aging, but
preventative efforts need to be lifelong. Individuals must be
assessed in terms of their medical history and predisposing
factors to determine their risk for low bone mass. Because
bone mass in men and women increases until about age 30
before beginning to decline, efforts in this population should be
directed toward maximizing peak bone mass. After age 30,
efforts must be directed toward preventing bone loss. Adults
with vertebral, rib, hip or distal forearm fractures should be
ev~luated for osteoporosis via bone mineral density testing.
Umversal recommendations to maximize and preserve bone
mass include: adequate intake of calcium and vitamin D,
regular ~eight bearing and muscle-strengthening exercises,
and avo1dance of both tobacco use and excessive alcohol
intake.
May is National Osteoporosis Prevention Month. Regardless
of the age of your patients, it is never too soon or too late to
think about bone health. The National Osteoporosis
Foundation's annual prevention campaign message for 2001
emphasizes the consequences of osteoporosis and the need
for all healthcare practitioners to take a preventative approach
with their patients -- "Every 20 seconds osteoporosis causes a
fracture."
If you are interested in more information related to
osteoporosis or bone mineral density testing, please contact
the Metabolic Bone Program at the Health Center at
Trexlertown at (610) 402-WELL.
(So~rce:

National Osteoporosis Foundation & Osteoporosis Learning
Senes: ACME-accredited self-study program}
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Experience the Newest Release of GUI Email

Congratulations!

The lnfonnation Services Department would like to invite you
to experience the newest release of GUI email. This newest
version takes minutes to install and provides many new
enhancements-- all done in response to user requests. GUI
email opens the door to allow you to keep your existing mail
files, yet provides you with a Windows-based interface to all
the luxuries that come with Windows: attachments (Word
documents, spreadsheets, pictures), PC composition options
(choice of fonts, colors, spell check, margins, etc.), archive of
your own files off-line if you wish (locally), and printing to local
printers (even in color, if one is available to you).

Mark A. Gittleman, MD, Division of General Surgery, has
been elected a Governor to the American College of Surgeons,
representing the American Society of Breast Surgeons.

lnfonnation Services would like to especially welcome on
board those of you who are still using the original email display
("Green Screen") and hope you will allow 1/S to bring your PC
up to the best it can be. Some are still usi~g th~ original .
version to print to an old nearby Fax mach1ne (v1a T###), wh1ch
is a carryover from the old days of five to seven years ago
when printers weren't as common, and it was your only option
to print locally. If you are among this group and are still
plugging away with the original green screen versi?n and .
printing to your old Fax machine, please contact e1ther Bame
Borger (Barrie.Borger@lvh.com, (610) 402-5715), or Rob Bortz
(Rob.Bortz@lvh.com, (610) 402-1482). One of these
individuals will schedule you STAT, ahead of the rest, to
replace these old, costly fax prints.
lnfonnal drop-in sessions, designed to help people convert to
the GUI E-mail from the older emulation system, have been
scheduled: Monday, May 7, from 1 to 3:45 p.m., and
Thursday, May 10, from 12:45 to 3:30p.m., both in Classroom
1 at Cedar Crest & 1-78. Everyone is welcome to drop in
during these times to ask questions or to get an overview of
GUI E-mail.

Thomas D. Meade, MD, Division of Orthopedic Surgery,
Section of Ortho Trauma, was recently appointed to sit on the
Executive Committee of the Alumni Association of Jefferson
Medical College. Jefferson Medical College boasts the largest
medical alumni association in the country.

Papers, Publications and Presentations
John A. Altobelli, MD, Division of Plastic Surgery, attended
the Third International Congress of the Society of Pelvic
Dysfunction in Cairo, Egypt, from March 14-18. He
participated in the panel on "Pelvic Reconstruction Following
Large Defects Following Removal of Cancer and Muscle
Transposition for Incontinence."
Keith R. Doram, MD, Chief, Division of General Internal
Medicine, along with two LVH Internal Medicine residents David Shields, MD, and lmhotep Boukman, MD -- presented
two posters at the 21st Annual Regional Meeting of the Society
of General Internal Medicine, held on March 16, at the
University of Pennsylvania campus in Philadelphia. The
posters were titled "Factors Associated with Colorectal Cancer
Screening Compliance" and "Colorectal Cancer Screening:
Urban vs. Rural Population. •
In addition, Dr. Doram and Yehia Y. Mishriki, MD, Division of
General Internal Medicine/Geriatrics, were co-authors of a
chapter in the recently released 3rd Edition of John Noble's
Textbook of Primary Care Medicine. The title of the chapter
is "Primary Care of the Eye."
Kelly M. Freed, MD, Division of Diagnostic Radiology, coauthored two articles. "MRI of Conjoined Twins Illustrating
Advances in Fetal Imaging," which was published in the
January 2001 issue of the Journal of Computer Assisted
Tomography, reviewed two cases of thoracoomphalopagus
twins. The first case, imaged a decade ago, required the use
of an intrauterine paralytic agent to reduce fetal motion. This
intervention is made obsolete by the advent of fast scanning
techniques which can provide fetal images in seconds.
The second article, "Nonenhanced Helical CT and US in the
Emergency Evaluation of Patients with Renal Colic:
Prospective Comparison," which was published in the
December 2000 issue of Radiology, evaluated 45 patients by
CT and US examination (kidney, ureters, bladder including
ureteral jets). The conclusion made was that noncontrast CT
was 96% sensitive in the diagnosis of nephroureterallithiasis
whereas ultrasound was 61% sensitive.
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Upcoming Seminars, Conferences and
Meetings

Mark A. Gittleman, MD, Division of General Surgery, was an
invited speaker at the TriCare Mid-Atlantic Region Breast
Imaging Training Seminar held in Virginia Beach, Va., on
March 8 and 9, where he presented "New Trends in Breast
Cancer Diagnosis and Treatment." In addition, Dr. Gittleman
was an invited participant and presenter at the International
Consensus Conference on Image-Detected Breast Cancer,
sponsored by the University of Southern California
Comprehensive Cancer Center, held in Palm Beach, Fla.,
March 22-24.

Topics to be discussed in May will include:

Gary S. Greenberg, DPM, Division of Orthopedic Surgery,
Section of Foot and Ankle Surgery, spoke at the meeting of the
Council of Teaching Hospitals of the American Association of
Colleges of Podiatric Medicine in Chicago on March 16 and 17.
Dr. Greenberg presented a lecture on evaluation of the
resident, and conducted several workshops on developing
faculty as educators.

•!• May 1 - "Colorectal Cancer Surveillance: Who Gets
Colonoscopy"
•!• May 8 - Stahler Rex Lecture -- "Where is the Genetic
Revolution Headed: Testing, Therapy and Engineering"
•!• May 15 - "Unanswered Questions"
•!• May 22 - "Recent Advances in Bacterial Meningitis"
•!• May 29 - "Approach to Peripheral Neuropathy"

Geoffrey G. Hallock, MD, Division of Plastic Surgery, recently
had an article published in the Journal of Plastic and
Reconstructive Surgery titled "The Plastic Surgeon of the
20th Century," which was originally presented at the American
Association of Plastic Surgeons' meeting in Laguna Niguel,
Calif.

For more information, contact Diane Biernacki in the
Deparmtent of Medicine at (610) 402-5200.

Vincent R. Lucente, MD, Acting Chairperson, Department of
Obstetrics and Gynecology, was the Visiting Professor for
Grand Rounds at the Greater Baltimore Medical Center on
March 16, where he lectured on "New Concepts in Lower
Urinary Tract Infections."

Medical Grand Rounds
Medical Grand Rounds are held every Tuesday beginning at
noon in the Auditorium of Lehigh Valley Hospital, Cedar Crest
& 1-78, and via videoconference in the First Floor Conference
Room at Lehigh Valley Hospital-Muhlenberg.

Pediatric Grand Rounds
"Novel Treatments for Atopic Dermatitis" will be presented on
Tuesday, May 15, beginning at 8 a.m., in the hospital's
Auditorium at Cedar Crest & 1-78.
For more information, please contact Kelli Ripperger in the
Department of Pediatrics at (61 0) 402-2540.

Guidelines to Respond to Critical Tetanus Vaccine Shortage for Adults and Adolescents
1. Anyone with three or more tetanus shots in the past will NOT need a Td booster (during the shortage)
2. Persons with 0, 1, 2 , or UNKNOWN prior tetanus shots WILL NEED a Td booster as part of wound management, prenatal,
travel, school, or occupational assessment
3. TETANUS PRONE wounds** require TIG (tetanus immune globulin) regardless of any need or lack of need for Td
immunization (** burns, avulsions, crush injury, penetrating wounds, neglected wounds, wounds contaminated with dirt or
feces, farm implement associated injuries, thermal injuries, electrical injuries).
It is strongly recommended that health care facilities take inventory of existing supplies of Tetanus vaccine and contact suppliers if
you foresee a shortfall using criteria of past usage needs.
Vaccine boosters that may be delayed by the shortage should be agendized for early 2002 for affected patients with a careful
explanation given the patient of the need to "catch up."
Presently, pediatric vaccine and guidelines seem unaffected by shortage predictions, but this may change with new information
and is unclear at present.
If you have any questions regarding this issue, please contact Luther V. Rhodes Ill, MD, Chief, Division of Infectious Diseases, at
(610) 402-8430, pager (610) 778-7291, or via email atluther.rhodes@lvh.com.
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Who's New

Address Change

The ~ho's New section of Medical Staff Progress Notes
co~tam~ an update of new appointments, address changes,
res1gnat1ons, etc. Please remember to update your directory
and rolodexes with this information. In addition, the Medical
Staff Directory is now available on the e-mail Bulletin Board -Directories. Updates will be made to the Medical Staff
Directory in e-mail at the beginning of each month.

James K. Hoffman, MD
Valley Sports &Arthritis Surgeons
2649 Schoenersville Road
Suite 101
Bethlehem, PA 18017-7326
(610) 317-3440
Fax: (610) 317-3443

Medical Staff

Status Change

Practice Changes

William Gee, MD
Department of Surgery
Division of Vascular Surgery
From: Active/LOA
To: Honorary

Bmdjar & Freeman Medical Associates, P.C.
(assumed practice of Dr. John M. Kauffman, Jr.)
);;> Jon E. Bmdjar, DO
);;> James J. Freeman, DO
);;> Maria L. Jones, MD
Jon E. Bmdjar, DO
1210 S. Cedar Crest Blvd.
Suite 3700
Allentown, PA 18103-6237
(610) 402-0011
Fax: (61 0) 821-1186
James J. Freeman, DO
Maria L. Jones, MD
4 W. Main Street
Macungie, PA 18062-1309
(610) 967-4993
Fax: (610) 967-6553
Amitabha Gupta, MD
(no longer affiliated with Andrew S. Kimmel, MD)
1588 Woodfield Drive
Bethlehem, PA 18015-5550
(610) 997-0381
David Meir-Levi, DO
(no .longer with Progressive Physician Associates Inc.)
Penpheral Vascular Surgeons, PC
1259 S. Cedar Crest Blvd., Suite 301
Allentown, PA 18103-6260
(610) 439-0372
Fax: (610) 439-8807
(Effective 5/1/2001)

Peter K. Ghatak, MD
Department of Medicine
Division of General Internal Medicine
From: Affiliate
To: Honorary
Christine E. Hinke, MD
Department of Medicine
Division of Physical Medicine-Rehabilitation
From: Provisional Active
To: Associate
Site of Privileges - LVH-M

Two-Year Leave of Absence
Philip L. Tighe, DMD
Department of Dentistry
Division of General Dentistry

Resignation
Colin Kopes-Kerr, MD
Department of Family Practice

Mamie P. O'Brien, DO
Ooining Lehigh Valley Ophthalmic Associates - 4/30/2001)

400 N. 171h Street, Suite 101
Allentown, PA 18104-5099
(610) 433-0450
Fax: (610) 433-4655

(Continued on Page 13)
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Resignations

Allied Health Staff

Janet S. Clark, RN
Physician Extender
Professional
(John J. Cassel, MD, PC)

Appointments
Jelena Dinic, CRNP
Physician Extender
Professional- CRNP
(Allentown Anesthesia Associates Inc- Lisa A. Keglovitz, MD)
Site of Privileges - LVH & LVH-M
Joshua Singer, DC, CNIM
Physician Extender
Technical
Intraoperative Neurophysiological Monitoring Specialist
(Surgical Monitoring Associates)
(Supervising Physician - Mark C. Lester, MD)
Site of Privileges - LVH & LVH-M
Baoqing Wang, MSc, DABNM
Associate Scientific
Clinical Neurophysiologist
(Surgical Monitoring Associates)
(Supervising Physician- Mark C. Lester, MD)
Site of Privileges - LVH & LVH-M
Lawrence R. Wierzbowski, AuD, DABNM
Associate Scientific
Clinical Neurophysiologist
(Surgical Monitoring Associates)
(Supervising Physician - Mark C. Lester, MD)
Site of Privileges - LVH & LVH-M
Six-Month Leave of Absence
David S. Glosser, SeD
Associate Scientific
Psychologist

Patricia L. Donley, RN
Physician Extender
Professional
(ABC Family Pediatricians- Scott Brenner, MD)
Margery A. Fettig, RN
Physician Extender
Professional
(John J. Cassel, MD, PC)
Ruth A. Gerchufsky, RN
Physician Extender
Professional
(The Heart Care Group, PC)
Deborah R. Miller, CRNP
Physician Extender
Professional
(ABC Family Pediatricians - Donald L. Levick, MD)
Karen A. Moffat, RN
Physician Extender
Professional
(Yeisley Carcliothoracic Surgery, LLC)
Angela M. Toro, CRNP
Physician Extender
Professional
(Oncology Specialists of Lehigh Valley)
M. Deborah Vilegi·Abad, RN
Physician Extender
Professional
(Raul M. Abad, MD)
H. Douglas Widdowson, MEd
Associate Scientific
Audiologist
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Dear Colleagues,
Thankfully, I have many opportunities to work with our Hospice Home Care team. Why
thankfully? Because without their support I would not have the resources I need to care
for my patients throughout the continuum of their cancer care.
Many of you use and appreciate these services-and for you, it takes no further
explanation of why Hospice is so important to our community.
Many others of you refer to Hospice, and your patients benefit from the care and
support which Hospice provides.
This letter is being written both to thank Hospice Home Care for the excellent work they
do, and to review with my physician colleagues what can be expected of them when
they make a referral to Hospice Home Care.
[1] Your patients deserve to live with their terminal illness in comfort and dignity.
Referral to Hospice well before the crisis of imminent death is always preferred.
Referral in the crisis of imminent death is understood as sometimes inevitable.
[2] Referral to Hospice is like any other professional referral, and the same professional
courtesies are expected. When making a referral, be clear about your role. If you
intend to continue as the attending of record during Hospice care, please be sure to
communicate that preference to Hospice intake, or to the person making the referral for
you. Be prepared to talk with the hospice nurse about your referral to ensure that the
appropriate care plan is undertaken with your direction. The Hospice nurse should
never be made to feel that her calling you is an inconvenience.
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If you intend to refer the patient to another physician, or to the Hospice Medical
Director, please take the time to make a personal call to the physician who will be
taking care of your patient to ensure, again, that the care plan you would wish for your
patient is initiated. An accepting physician should never get an initial call from Hospice
to the effect that Dr. So and So has referred Mrs. Who and Whom to Hospice, and
"orders are needed."
[3] As the course of illness proceeds, care needs for the patient and family may change.
Again, the Hospice nurse should always feel comfortable communicating these
changes to you and to ask advice about making changes in the care plan.
[4] To assist you in your care of the Hospice patient, a small task force under the
leadership of Dr. Salerno is developing "order sets" which will provide guidelines for you
and for the nurse for initial management of common symptoms experienced by the
home hospice patient-such as, nausea, bowel problems, pain, anxiety, and the like.
These guidelines should lead to more informed communication between you and the
caring home nurse.
Last, when you think of Hospice, think of how you would want you or a member of your
family to be cared for at the time of dying. When that time comes for all of us, we know
for sure that we will want to be comfortable, and we do not wish to be alone. Hospice
home care ensures that our patients will be as comfortable as possible, and that the
patient and family we have cared for will not be alone in their journey.
Please join me in thanking our Hospice team for their extraordinary efforts, and for
helping us take better care of our patients.
Yours Sincerely,

Gre(£~:2. M~

Physician in Chief, Cancer Services
Lehigh Valley Hospital and Health Network
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News from the Library
OVID Training.
The Library has completely converted to OVID's online MEDLINE system. This Web-based system is
updated daily by Ovid. Call Barbara lobst in the
Health Sciences Library at 610-402-8408 to schedule
a one-on-one training session.

Computer Based Training takes place in Suite 401 of the
John & Dorothy Morgan Cancer Center (the computer
training room) and in the Muhlenberg Hospital Center
computer training room (off the front lobby). The schedule
of upcoming dates is as follows:

New Library Publications.
CBT sessions for JDMCC, suite 401 are as follows:

CC & I-78
"Textbook of Natural Medicine," 2nd edition
LVH-Muhlenberg
"Sabiston Textbook of Surgery: The Biological Basis of
Modem Surgical Practice," 16th edition
17th & Chew Streets
"DeGowin's Diagnostic Examination," 7th edition

Computer-Based Training (CBT):
Computer Based Training (CBT) programs are available for
LVHHN staff. Topics covered by the CBT programs include:
Access 2.0
Power-Point 4.0
Windows NT 4
Word 97
Excel 97
Access 97
PowerPoint 97
Lotus 1-2-3 Millennium
E-mail GUI
WordPerfect 8
PHAMIS LastWord Inquiry Only commands
CBT programs replace the instructor-led classes previously
held at Lehigh Valley Hospital. A proctor will be in the room
with the learner while he/she takes the CBT, but the learner
will control the pace and objectives of the learning.

1

May 8,
8 am- Noon
June 26, Noon- 4 pm
August 7 8 am - Noon
Sessions at MDC, I.S. Training room are as follows:
July 17,

Noon-4pm

Twelve slots are available for each session.
To register, please contact Suzanne Rice via e-mail or at 610402-2475 with the following:
date of session
second date choice
department
phone number
You will receive an e-mail conlmning your choice within two
business days. If you have any questions, please contact Craig
Koller at 610-402-2413 or through e-mail.

Any questions, concerns or comments on articles from CEDS, please
contact Bonnie Schoeneberger 610-402-2584

Sunday

Monday

Tuesday

Wednesday

Thursday

Friday

Saturday

May 2001
1

7am Family Practice GR JDMCC 1AIB
7am Surgical GR-CC-Aud
Bam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud

6
13

2

27

4

12noon Combined TBJDMCC-CR1

7am GYN Tumor BoardCC-CL1
12noon Breast TB-JDMCCCR1

7

8

9

10

12noon Colon/Rectal
TB-JDMCC-CR1

7am Surgical GR-CC-Aud
Sam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud

12noon Pulmo TBJDMCC-CR1

12noon ENT TB-JDMCCCR1

14

15

16

7am Surgical GR-CC-Aud
Bam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud

20

3

12noon Endo TB-JDMCCCR1

23

21

22

12noon Colon/Rectal
TB-JDMCC-CR1

7am Surgical GR-CC-Aud
Bam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud

28

29

24
12noon Cancer Comm. JDMCC-CR1

30

7am Surgical GR-CC-Aud
Bam Pediatric GR-CC-Aud
12 noon Medical GR-CCAud
12noon Urology TBJDMCC-CR1
-----

17

5

11

12

18

19

25

26

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

7am OBGYN GR-CC-CL 1
12noon Breast TB-JDMCCCR1

31
12noon Combined TBJDMCC-CR1

""tJ

I»
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CD
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co

~---------

----
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NEWS FROM THE
HEALTH INFORMATION MANAGEMENT

DEPARTMENT
(MEDICAL RECORDS)
Volume 1, Issue 1

April2001

Document Imaging
Upgrade- LVHCC/17/WG
The PIM 2.0 Document Imaging Historical Medical
Record Access and Electronic Chart Completion
System will be upgraded on Tuesday,
May 15,2001 to the EPF PIM 4.0 system

Downtime Procedures
Tuesday, 5/8/01 -Monday 5/14/01
•

Medical record discharges from Sunday,
May 6, 2001- Monday, May 14,2001 will be
available at the CC site HIM Department for
review in the original paper format.

•

Transcribed H&P, DS, Consults, Ancillary
Results and Lab Cums will continue to be
available via the Phamis IDX system during
the downtime.

•

The HIM Department will be staffed at the
Cedar Crest location 24 hours a day during the
downtime and data conversion.

•

The HIM Department will have the ability to
print/fax medical records for patient care and
release of information.

•

Paper medical records will not be released
from the HIM Department during downtime
due to prepping processes for scanning
following the conversion. Paper medical
records must be reviewed in the HIM
Department at the CC site.

•

Abstracts will continue to be sent to the units
for re-admits either from printed images or
photocopies of paper records.

•

Requests for paper medical records should be
made by calling the HIM Department at 4028240 (option 3).

Data Conversion
Tuesday 5/8/01-Monday 5/14/01
During the data conversion period, the Imnet PIM
2.0 System will continue to be available in a "read
only" mode with historical medical records from
August 1998 through Saturday, May 12, 2001.
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Electronic
Signature/Chart
Completion
During the downtime and data conversion,
physicians/clinicians will be unable to access the
imaging system to complete medical record
deficiencies.
•

•

Physicians/clinicians are encouraged to come
to the HIM Department at the CC site to
complete any outstanding dictations (history
and physicals, operative reports, discharge
summaries, consults, etc.). This will prevent
interruption in patient care and allow the
facility to have appropriate documentation to
avoid delays in the billing/reimbursement
process.
There will be no telephone notification for
delinquent records from May 7, 2001 May 25, 2001 during downtime, conversion,
and catch-up processes. It is anticipated that
normal processes will resume the week of
May 28, 2001.

Hardware Upgrade

•

AutoSign - Allows automatic presentation of
documents for electronic signature with the
ability to sign the entire batch at one time.

•

Demographic Search - Allows more
functionality, including moving from patient
to patient on the same screen.

•

User-Defined Record View- Allows users to
set up and change his/her own record view
(documents to be viewed).

•

Missing Text- Gives clinician the ability to
add missing text to imaged documents
(transcription, written documents, etc.).

Software Download
The Window below will appear ifPIM 4.0 has not
been loaded on the PC you are using. The load
process will take approximately 10 minutes to
perform. Please be patient while this process
completes the installation of the new software.

Information Services will upgrade the hardware
and clinical workstations to provide increased
capacity. This upgrade will quadruple the optical
disk capacity while providing additional servers.

Software Upgrade
The software upgrade will provide additional
features for the clinicians and Health Information
Management Department. Some of the new
features that will impact clinicians include:
•

Physician Groups - Allows definition of
physician groups with the ability to complete
deficiencies for group members.

NEWS FROM TilE HEALTH 2
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HIM Website
Visit the Health Information Management home
site on the LVHHN intranet home page for
updated information on the document imaging
upgrade and other HIM related topics.

Physician/Clinician
Computer Based
Training (CBT)
Visit the HIM Website on the LVHHN Intranet
home page for computer based training for
medical record access and electronic chart
completion

LVH-M Implementation
Implementation of Document Imaging record
access and physician/clinician electronic chart
completion is coming in June 17,2001. Stay
tuned for more information on specific dates,
training, etc.
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CHEMISTRY

LABORATORIES

LAB .. LINK
Information And Advice About Our Laboratory

Effective May 1, 2001

THYROID TESTING UPDATE
To simplify thyroid test ordering, effective May 1, 2001 the following codes will be
utilized:
lest Name

lest Code

Normal Range

Low End
Reportable Range

Thyroid Stimulating Hormone

TSH

0.465- 4.680 uiU/ml

0.003 uiU/ml

T4 , Free (Thyroxine)

FT4

0. 78 - 2.19 ng/dl

0.030 ng/dl

T4 , Total (Thyroxine)

T4

5.50 - 11.00 ug/dl

0.300 ug/dl

T 3 , Free (triiodothyronine)

FT3

2. 77 - 5.27 pg/ml

0.390 pg/ml

T3 , Total (triiodothyronine)

T3T

0.96- 1.69 ng/ml

0.10 ng/ml

T" Uptake (thyroid binding index)

T3U

23.50 - 40.60%

17.0%

PLEASE NOTE:
•

The THYROID PROFILE (TH7) which contains a calculated index will
NO LONGER BE AVAILABLE as of May 1, 2001 due to the increased
sensitivity of the above tests.

•

The T4 , Total and TSH tests have been removed from the critical call
back notification list.

If you have any questions, please call our Customer Care Call Center at
610-402-8170.
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THERAPEUTICS AT A GLANCE
The following actions were taken at the March 2001 Therapeutics Committee Meeting- Fred Pane, Director of Pharmacy,
Clinical Pharmacy Services- Joseph Ottinger, R.Ph., MS, MBA, Christopher Moore, R.Ph., Janine Barnaby, R.Ph.

Pharmacy
Operations
Improvement - Update First
Quarter FY'Ol
One of the responsibilities of the
Therapeutics Committee, a Medical Staff
Committee, is to assist the Pharmacy
Department in identifying Operations
Improvement (01) and implementation.

If you have 01 suggestions, please contact
Fred Pane, R.Ph., Director of Pharmacy at
610-402-8881. Thank you for your ongoing
support.

01 Project Examples:
Cost/day
$18.00

A.

A number of programs have been successful,
in helping to generate an estimated savings
of$669,877 over the last 18 months at
Lehigh Valley Hospital and $110,047 at
Lehigh Valley Hospital - Muhlenberg.

Claforan 1gm Q8H IV
Claforan 1gm Q12H IV
(renal dose)
$12.00
Rocephin 1gm Q24H IV $38.85
(restricted to Pediatrics and
Meningitis)

B.

For the first 6 months ofFY'01 (July to
December) an estimated $377,758 was
achieved, through the support of the Medical
Staff, at Lehigh Valley Hospital, alone.

Levaquin 500mg Q24H IV $15.25
Levaquin 500mg Q24H PO$ 5.93
Cipro 400mg Q12H IV
$47.00
(restricted usage)

C.

Some of the ongoing 01 projects include:
a)
Therapeutic Substitution of Claforan
for Rocephin, Levaquin for Cipro,
Zocor for Lipitor, Zemuron for
Nimbex (ventilator patients),
Retavase for tPA (MI's and IR).
b)

c)

IV to oral step down therapy of
Levaquin, Diflucan, Flagyl, Zofran
and Zithromax.
Formulary Management

The pharmacy department continues to
benchmark with national leaders in
healthcare and works with groups like The
Advisory Board in Washington, DC.

Zocor 5mg QD PO
Zocor 10mg QD PO
Zocor 20mg QD PO

$0.11
$0.14
$0.25

Lipitor 1Omg QD PO
(not formulary)
Lipitor 20mg QD PO
(not formulary)

$1.65
$2.55

Drug Formulary IssuesAggrenox, Pletal, Chirocaine
Aggrenox (Aspirin 25 mg/extendedrelease dipyridamole 200 mg) capsules are
approved for the reduction of the risk of
stroke in patients who have had transient
ischemia of the brain or completed ischemic
stroke due to thrombosis.
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CLINICAL PHARMACOLOGY:
Aspirin and dipyridamole are antiplatelet
drugs. Aspirin works by irreversibly
inhibiting the platelet cyclo-oxygenase and
decreasing the production of thromboxane
A2 • Dipyridamole works by inhibiting the
reuptake of adenosine into the platelets,
endothelial cells, and erythrocytes. The
increased adenosine levels stimulate the
platelet A2-receptor that activates platelet
adenylate cyclase and increases the platelet
cyclic-3 '-5 '-adenosine monophosphate
(cAMP) levels. This results in the inhibition
of platelet aggregation. Dipyridamole also
inhibits phosphodiesterase (PDE) in other
tissues of the body. The inhibition of cAMP
and cyclic-3 '-5' -guanosine monophosphatePDE (cGMP-PDE) is weak, but the levels of
each are increased in various tissues. The
impact on cGMP is greater since
endothelium-derived relaxing factor (nitric
oxide) plus dipyridamole can each augment
the other's activities.
PHARMACOKINETICS: Peak plasma
concentrations of aspirin are achieved within
1 hour. The aspirin is hydrolyzed to
salicylic acid in the liver and gastrointestinal
wall. Peak plasma salicylic acid levels are
reached within 1 hour. The systemic
bioavailability of aspirin is 50% to 75%.
The apparent volume of distribution in 10 L.
The protein binding of aspirin is low, but its
metabolite (salicylic acid) is highly protein
bound (90%). The half-life of aspirin is 20
minutes, and the half-life of salicylic acid is
1.71 hours at lower doses. The half-life of
salicylic acid is dose dependent and will
increase with dose. Peak plasma
concentrations of dipyridamole are achieved
within 2 hours with the extended-release
formulation. The peak plasma
concentrations are increased by 40% in
geriatric patients. The steady-state volume
of distribution is 92 liters. Protein binding is

99%. The drug does not cross the blood
brain barrier, but is highly lipophilic. It is
primarily metabolized by the liver to its
monoglucuronide, which is a weak active
metabolite. The terminal half-life of
dipyridamole is 13.6 hours at lower doses.
The half-life of salicylic acid is dose
dependent and will increase with dose.
Administration of aspirin and dipyridamole
does not alter the pharmacokinetics of either
agent.
ADVERSE REACTIONS: The most
common adverse effects associated with
aspirin 25 mg/extended-release
dipyridamole 200 mg therapy included
headache, dyspepsia, abdominal pain,
nausea, diarrhea, and vomiting . A complete
list of the adverse effects reported with
aspirin 25 mg/extended-release
dipyridamole 200 mg can be found in the
product labeling.
DRUG INTERACTIONS: No drug
interaction studies have been conducted with
the aspirin 25 mg/extended-release
dipyridamole 200 mg formulation. See the
drug interactions reported in the product
labeling; they are based on those reported
with aspirin or dipyridamole therapy alone.
DOSING: Aspirin 25 mglextended-release
dipyridamole 200 mg capsules should be
given orally twice daily, in the morning and
evening. Each capsule should be swallowed
whole and should not be crushed or chewed.
CONCLUSION: The combination of
aspirin and dipyridamole may be better than
aspirin alone in the prevention of stroke in
patients with a prior history of stroke or TIA
according to data from the European Stroke
Prevention study 2 trial. This trial analysis
was also the basis for a similar declaration in
the Chest guidelines on stroke prevention
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(grade lA) Since the studies done with
Aggrenox used a special formulation of
aspirin and dipyridamole, the results of these
trials cannot be applied to the combined use
of separate prompt-release aspirin and
dipyridamole products. Clinical
comparisons of this formulation with
ticlopidine and clopidogrel are not available.
Pletal (Cilostazol) is approved for use in the
treatment of intermittent claudication. The
drug is also being studied for use in poststroke syndrome, the prevention of recurrent
stroke, prevention of thrombosis and
restenosis after stent placement, prevention
of restenosis after angioplasty and the
prevention of graft occlusion.
CLINICAL PHARMACOLOGY:
Cilostazol is a potent and selective inhibitor
of cGMP-inhibited cAMP
phosphodiesterase (PDE type 3, PDE3).
Cilostazol inhibits platelet aggregation,
including platelet aggregation induced by
stress, ADP, collagen, arachidonic acid and
epinephrine.
PHARMACOKINETICS: Peak plasma
concentrations occur 2 to 4 hours after oral
administration. Absorption appears
unaffected by administration with food.
Peak anti-aggregatory effects are observed at
6 hours after oral administration. Cilostazol
is extensively plasma protein bound,
primarily to albumin. The mean terminal
half-life is 12 to 26 hours, although it has
not been well characterized due to apparent
biphasic elimination. The distribution halflife is 2 to 3 hours, and the terminal half-life
is 18 to 26 hours. Cilostazol is metabolized
primarily by hydroxylation to numerous
metabolites, which have half-lives
comparable to the parent drug. Unchanged
cilostazol is not detected in the urine.

Pharmacokinetics have not varied with age
or by gender.
ADVERSE REACTIONS: The most
common adverse effects are headache,
diarrhea, abnormal stools (loose stools),
palpitation and dizziness, with headache
occurring most frequently. Discontinuation
of therapy due to side effects was reported
for 16% of cilostazol-treated patients
compared to 9% of placebo-treated patients
in clinical trials. Headaches were most
frequently described as mild and responded
to nonprescription analgesics. Animal
studies have shown cardiovascular lesions,
including endocardial hemorrhage,
hemosiderin deposition and fibrosis in the
left ventricle, hemorrhage in the right atrial
wall, hemorrhage and necrosis of the smooth
muscle in the wall of the coronary artery,
intimal thickening of the coronary artery and
coronary arteritis and periarteritis.
Pregnancy data are not currently available.
In animal studies, cilostazol was excreted in
breast milk at concentrations of 41% to 72%
of blood concentrations.
DRUG INTERACTIONS: Drugs that
inhibit the CYP3A4 and CYP2C19
isozymes will decrease the clearance and
increase the peak plasma concentrations of
cilostazol or its metabolite. Examples of
CYP3A4 inhibitors are ketoconazole,
itraconazole, erythromycin, diltiazem and
grapefruit juice. An example of a CYP2C19
inhibitor is omeprazole. Erythromycin
increases the peak plasma concentration of
cilostazol by 47% and the AUC by 73% and
increases the AUC of the 4'-trans-hydroxycilostazol by 141%. Diltiazem increases the
peak plasma concentration by 53%
Omeprazole does not affect the metabolism
of cilostazol, but does affect the elimination
of the 3 ,4-dehydro-cilostazol metabolite.
The levels of this metabolite are increased
by 69%. Aspirin plus cilostazol may further
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decrease platelet aggregation, but it has no
clinically significant impact on bleeding
time compared to aspirin alone.

DOSING: Cilostazol has been dosed at 100
mg twice daily in the treatment of
intermittent claudication and in the
treatment of ischemic symptoms such as
ulcer, pain and cold sensation due to severe
peripheral arterial disease. The
recommended adult dosage of cilostazol is
100 mg twice daily. The tablet should be
taken at least half an hour before or 2 hours
after breakfast and dinner. A lower dose (50
mg twice daily) should be considered if the
patient is receiving concurrent therapy with
ketoconazole, itraconazole, erythromycin,
diltiazem or omeprazole. The patient should
also be instructed to avoid grapefruit juice.
Safety and effectiveness studies have not
been conducted in children.

CONCLUSION: Cilostazol appears to
produce moderate improvements in walking
distance in patients with intermittent
claudication and may prove useful as an
alternative to pentoxifylline in this
indication. Recent mutlticenter, randomized,
placebo-controlled trials have shown its
benefits with stable PAD compared with
placebo and pentoxyfylline.
Dr Shaheen presented data on 200 patients
that were treated with Chirociane
(levobupivicaine) vs. ropivicaine for
peripheral nerve blocks. According to his
presentation, patients receiving
levobupivicaine obtained a satisfactory level
of blockade comparable to bupivicaine and
ropivicaine. Additonally, the duration of
action was comparable to bupivicaine, but
this activity was provided without concerns

related to the potential cardiotoxicity
associated with large instillations of
bupivicaine. The duration of effect was
superior to that associated with ropivicaine,
and can be provided at a lower cost
compared with that agent.

INDICATIONS: Levobupivacaine is
indicated for the production of local or
regional anesthesia for surgery and
obstetrics, and for post-operative pain
management..

CLINICAL PHARMACOLOGY:
Bupivacaine is a racemic agent composed of
R-(+) and S-(--) enantiomers.
Levobupivacaine (S-(--)-bupivacaine) is an
enantiomer of bupivacaine. Due to its long
duration of action, bupivacaine is the most
frequently used local anesthetic in epidural
and peripheral nerve anesthesia; however, it
is associated with considerable central
nervous system and cardiovascular toxicity.
The R-(+) enantiomer ofbupivacaine is
associated with greater CNS and cardiac
toxicity. R-(+) bupivacaine is more potent
than S-(--)-bupivacaine with regard to
blocking of sodium and potassium channels.
Because the R-(+) enantiomer is more potent
at blocking cardiac sodium channels, the S(--) enantiomer was pursued in hopes it
would be associated with less cardiac
toxicity. Ropivacaine, a propyl homologue
of bupivacaine, is also an S-(--)-enantiomer
which offers an improved safety profile
compared to bupivacaine.
In animal studies, bupivacaine decreases
cardiac output, myocardial contractility,
myocardial blood flow, and intracardiac
conduction velocity, and induces ventricular
arrhythmias. Levobupivacaine also induced
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QRS widening and ventricular arrhythmias,
but at higher doses than bupivacaine and the
reactions occurred less frequently and were
less severe. In animal studies,
levobupivacaine was also associated with
less CNS toxicity than bupivacaine.

Levobupivacaine is included in Pregnancy
Category B. Caution is recommended when
levobupivacaine is administered to a nursing
woman. The excretion oflevobupivacaine
or its metabolites in human milk has not
been studied.

Levobupivacaine causes more
vasoconstriction than the other enantiomer,
resulting in delayed drug uptake from the
site of administration and prolonged clinical
effect

The safety and effectiveness of
levobupivacaine in pediatric patients have
not been studied.

No studies compared levobupivacaine and
ropivacaine.
CONTRAINDICATIONS, WARNINGS,
AND PRECAUTIONS: Levobupivacaine
is contraindicated in patients with a known
hypersensitivity to levobupivacaine or to
any local anesthetic of the amide type.
Levobupivacaine should not be used for
intravenous regional anesthesia (bier block)
or for obstetrical paracervical block
anesthesia.
Unintended intravenous injection may result
in cardiac arrest. Prolonged resuscitation
may be required. Levobupivacaine should
be administered in incremental doses. Since
it should not be injected rapidly in large
doses, it is not recommended for use in
emergency situations where a rapid onset is
desired.
Levobupivacaine should be used with
caution in patients with hepatic dysfunction,
hypotension, hypovolemia, or impaired
cardiovascular function, particularly heart
block.

ADVERSE REACTIONS: Adverse
effects observed in more than 5% of
levobupivacaine-treated patients in studies
have included hypotension, nausea, postoperative pain, fever, vomiting, anemia,
pruritus, pain, headache, constipation,
dizziness, and fetal distress.
Levobupivacaine may produce small
increases in the PR interval and the
corrected QT interval.
In animal studies, convulsions and
excitatory CNS symptoms occurred at a
lower dose with bupivacaine than with
levobupivacaine.
DRUG INTERACTIONS: Although
studies have not been conducted, it is likely
that CYP3A4 inducers and inhibitors and
CYP1A2 inducers and inhibitors may affect
the metabolism of levobupivacaine.
DOSING: Dosage recommendations for
levobupivacaine are included in the product
labeling and vary according to its indication
for use.
CONCLUSION: Dr Shaheen presented
some data for use of levobupivicaine in lieu
of ropivicaine in selected procedures.
Levobupivicaine appeared to provide a level
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of effectiveness comparable with
bupivicaine and ropivicaine without the
potential cardiotoxicity of the former and for
a longer period of time than the latter.
Additionally, levobupivicaine provided a
cost advantage vs. ropivicaine in the
population observed.
Drug interactions with enteral products
A revision to the policy coordinating the
time of administration of selected
medications with enteral feedings was
approved. Pharmacy will be placing an
interaction notice on the Nursing Medication
Administration Record (MAR) to more
clearly identify 'problem' issues and the
recommended resolutions. A copy of the
notification form is included below:

Lehigh Valley Hospital-Muhlenberg
Hospital
Enteral Feeding/Drug Interaction Notice
Patient N arne:
Nursing Area: _ _ _ __
Date:

-----------------------

----------------------

As per the Therapeutics Committee, the
following agents have been identified as
requiring administration on an "empty
stomach". Your patient is currently
receiving the drug(s) checked below.
Please, follow the instructions
appropriate to each item and adjust your
MAR accordingly. If you have any
questions, please, contact the Pharmacy.
___ lansoprazole (Prevacid)-stop tube feeding
l hour per- and post dose.
___ phenytoin (Dilantin)- stop tube feeding 2
hours pre- and post dose
___ theophyllin- stop tube feeding l hour
pre- and post dose.

___ levothyroxine (Synthroid, Levoxyll -stop
tube feeding l hour pre- and post dose
___ digoxin (Lanoxin)- stop tube feeding 1
hour pre- and post dose. ONLY IF SUPPLEMENT
CONTAINS FIBER (i.e., Jevity)
___ quinolones
(Ciprofloxacin,Cipro;Levofloxacin,Levaquin)stop tube feeding 30 minutes pre- and 1 hour
post dose.

Please, adjust the tube feed goal rate
accordingly.

pt\30l.hi
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Pennsylvania Medical Society Physician Alert
(This information is bring provided to you by Robert X. Murphy, Jr., MD, OMSS Representative)

Subject: Medical Liability Matters
Liability Reform Action Center: 1-800-566-TORT (8678)

State Society's Medical Liability Reform Legislation Readied for Spring 2001 Introduction
While opposing several ill-advised CAT Fund reform measures now under House and Senate committee
study, the Society is readying its legislative proposal for medical liability reform for introduction. The
Society's proposal includes:

*

CAT Fund reforms, and possibly abolishment, without financially burdening physicians,
particularly young physicians who had nothing to do with the current crisis.

*
A collateral source rule that allows juries to be informed if the victim will be compensated by
other sources for losses such as wages and health care costs.
*

A voluntary arbitration system that would be binding only if the patient chooses to sign a
contract. Act 111 of 1975 included mandatory binding arbitration, but that portion of the measure was
struck down by the courts.

*
An expert witness rule that requires the witness to be board-certified if appropriate, and have the
same qualifications as the defendant.
*

Measures to clarify informed consent language in the existing law.

*

Compensation for the PIC and PIE insolvencies to offset one year of these costs.

*
Measures to strengthen the medical, osteopathic, and podiatric boards that would enable the
boards to hire additional staff and to fully implement the boards' authority.
*

An exemption for retired physicians from current mandatory CAT Fund participation.

The Society's legislative strategy is a multi-phase approach, with the initial measure introduced in 2001
and successive long-term measures. We believe that the answer to gaining medical liability reform lies in
a mix of medical liability insurance, tort, and CAT Fund reforms that are strong enough to withstand
attempts by the legislature to water them down and by the courts to strip them of any authority.
At the same time that our initial legislative measures move forward, we will continue to work toward
judicial and legal system reforms, greater public awareness of the urgent need for reform, and developing
patient safety and quality initiatives.
Key to the Society's long-term campaign is the enactment of a constitutional amendment to remove the
state's prohibition against caps on non-economic damages. Because this requires a multi-year legislative
procedure and a public referendum, the Society is preparing to commit substantial resources to this goal.
Watch for further details as the Society moves these reforms forward in the next few weeks. Go to

http:/ /www.lrac@pamedsoc.org/ www.lrac@pamedsoc.org, or call the LRAC for more
information at 1-800-566-TORT (8678).
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Doctors Descend on Lawmakers in Capitol on Tuesdays
On Tuesday, March 13, the halls of the Capitol were dotted with white coats as more than 120 physicians
from southeastern Pennsylvania loudly warned lawmakers of the urgent need to "Save Pennsylvania
Medicine." This was not a rally on the scale of the 1996 "Tort Reform Now!" statewide physician rally
held by the Society, but rather the first in a series of waves of physicians to descend upon Harrisburg's
legislators on Tuesdays from now until the close of session in May. Another 50 physicians joined the fray
on March 20, and hundreds more are slated to come later this spring.
The strategy this time around, said State Society President Carol E. Rose, MD, is to "tell them our
stories." Physicians must come to Harrisburg to personally tell lawmakers their stories about how the
medical liability crisis is affecting their ability to serve their patients in their communities. "Tell them
how you can't recruit a partner; why you're retiring early; how you've put off buying new equipment or
cut back on higher-risk procedures like delivering babies," Dr. Rose told participants.
"We couldn't have had a more eloquent, impassioned group of physicians than we had today," Roger
Mecum, the Society's executive vice president, said following the first "Tuesdays in Harrisburg" event.
He noted that legislators were responding positively to the physicians' visits, and the event received wide
media coverage.
The physicians were also asked to briefly explain to legislators why the Society opposes House Bill 649
and Senate Bill556. Both bills would privatize the CAT Fund. While the Society supports privatization,
we believe the bond proposal in HB 649 would be far too costly and would essentially mortgage the
future for physicians.
Physicians are urged to join us by region for Tuesdays in Harrisburg. Dates still available are April 24,
May 1, May 8, and May 22. If you'd like to join us at the Capitol, call the Liability Reform Action Center
at 1-800-566-TORT (8678) for more information.

What's Your Story? We Care!
Our recent experience in the Capitol proves one basic political rule: The story of the individual always
makes the greatest impact to the press and lawmakers. Physician's individual accounts of how the medical
liability crisis is changing their relationships with patients and with their communities are the most
powerful tools we have to get our message across.
What's your personal story?

*
Has the cost of my medical liability premiums caused my colleagues or me to practice medicine
differently in 2001 than we did in past years? How has this affected my patients or my community?
*
Has my practice or my hospital, or any other health care facility in my community, had difficulty
recruiting new physicians? What comments have new doctors made about practicing in Pennsylvania?
*
Have medical liability premiums changed my retirement or business decisions?
*
In five years, if the medical liability crisis continues, what affects to their access to health care
could my patients expect to suffer? How will my relationship with my patients be different?
Once you have composed answers to these questions, tell the governor, your patients, your legislators,
and the State Society your story. It's important to focus on the impact on your patients and your
community-and to stick to that point! You can make a difference.
What Can YOU Do?
Call the governor: Call Tom Ridge at (717) 787-2500. Let him know you will detail your experiences in a
personal letter. Be sure to fax a copy to the Society at (717) 558-7840.
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Tell us how the crisis affects your practice and your patients:
Is it difficult to hire new physicians? Thinking of retiring? Have you cut back on services? Laid off staff?
Email us at lrac@pamedsoc.org <mailto:lrac@pamedsoc.org> or fax (717) 558-7840, telling us how
skyrocketing premiums and CAT Fund payments have affected your practice.
Identify your legislator: To identify your legislator, go to www.pamedsoc.org
<http://www.pamedsoc.org/>, click on advocacy & information, legislation/regulation, "look up your
congressman."
Join P AMPAC: Trial lawyers give generously to their political action committee (PAC). Doctors don't.
Send a personal contribution to PAMPAC, Box 8820, Harrisburg, PA 17105-8820.
Help us contact local media: Know any local media personalities? Call Chuck Moran, ext. 1437.
Come to Harrisburg: Join us at the Capitol-call the Liability Reform Action Center for information at 1800-566-TORT.
Get your patients involved:
Brochures and posters are available from the LRAC.
Got Them On Hold?
Here's a sample of the type of message you can record for those on hold with your office:
Thank you for holding. We will serve you as quickly as possible. While you wait, you may be interested
to know that there is a medical crisis in Pennsylvania. The high cost of malpractice insurance is driving
physicians out of the state. Other physicians aren't doing high-risk procedures anymore. And young
physicians aren't coming to our state to practice. Politicians in Harrisburg are slow to take action because
lawyers who sue doctors make big campaign donations. When you can't find a doctor, what will you do?
Act now. Ask us for details on how you can help save Pennsylvania medicine.
Answering machine messages for patients
A very brief message inserted into your answering system may help break the ice in discussing the crisis
with patients. Here are some suggestions:
Message 1: Hello. You have reached [name of practice]. Our top priority is preserving a positive
relationship with our patients. That's getting harder and harder in the face of the medical liability crisis in
Pennsylvania. Ask us for details ....
Message 2: Hello. You have reached [name of practice]. When you come to see us, please ask us about
the medical liability crisis in Pennsylvania. We think you'll be interested by what you hear ...
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